{"database": "lobbying", "table": "lobbying_activities", "rows": [[989897, "7d65f347-dd02-45c6-8e9a-1707e17ed0a3", "Q3", "THE PETRIZZO GROUP, INC.", 305932, "AGIOS PHARMACEUTICALS, INC.", 2010, "third_quarter", "MED", "Advance proposal for federal funding in the FY 2011 Defense Appropriations bill for cancer metabolism drug discovery that will bring therapeutic hope to service men and women who are suffering from Acute Lyeloid Leukemia and brain cancer (gliomas).", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2010-10-12T09:58:36.890000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["989897"], "units": {}, "query_ms": 12.716762954369187, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}